Showing 421-430 of 8528 results for "".
Pearls for Management of Pediatric Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-pediatric-management-atopic-dermatitis/27122/At the recently held 2024 American Academy of Dermatology (AAD) Innovation Academy dermatologist Lisa Swanson, MD, FAAD, presented new insights into pediatric atopic dermatitis (AD), emphasizing its wide-ranging impact on children's health, including increased risks of food allergies, infections, anFDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.Advances in Topicals for Skin Conditions
https://practicaldermatology.com/topics/psoriasis/advances-in-topicals-for-skin-conditions/20197/There are more topicals available today than ever before for acne, rosacea, and psoriasis, and even more are coming down the pike. Larry Green, MD, reviews the current topical landscape in dermatology and previews what’s in the pipeline.Effective Patient Consultations: Keys to Success
https://practicaldermatology.com/topics/practice-management/effective-patient-consultations-keys-to-success/20122/So much depends on the patient consultation, and its key that all members of the practice staff are attentive to the needs of the patient and the practice. Amy Lewis, MD and Mark Rubin, MD weigh in on strategies for effective patient interactions.DermWireTV: Olumiant Approved for AA; Radiesse + Launch; Derms as Influencers; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-olumiant-approved-for-aa-radiesse-launch-derms-as-influencers-vcs/20107/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. Dermatologists rank as top influencers of consumers’ decisions to have cosmetic procedures, according to results of the American Society for Dermatologic Surgery (ASDS) Consumer SurveyThe ABCDEs of AI for Skin Cancer Detection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-abcdes-of-ai-for-skin-cancer-detection/23695/Key considerations for dermatologists as AI continues to expand.Case Reports: Aesthetic Dermatology Successes
https://practicaldermatology.com/conferences/maui-derm-2022/case-reports-aesthetic-dermatology-successes/20050/Ava Shamban, MD highlights three cases she presented to show why she uses a carboxy lift mask to promote healing and improve side effects from laser procedures; the benefits of the Revance RHA Collection of Fillers to treat dynamic lines and wrinkles; and the effectiveness of hyperdilute Radiesse toScientifically Speaking: The Expanded Role for Microneedling
https://practicaldermatology.com/series/scientifically-speaking/the-expanded-role-for-microneedling/20011/What's the role for microneedling in today's practice? What are the best strategies to optimize outcomes? In this edition of Scientifically Speaking, host Joel L. Cohen, MD gathers expert insights from Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD.DermWireTV: AAD VMX Highlights, Upneeq Launches for Ptosis
https://practicaldermatology.com/topics/practice-management/dermwiretv-aad-vmx-highlights-upneeq-launches-for-ptosis/19931/The American Academy of Dermatology's VMX format delivers updates on a range of hot topics in dermatology, including an update on the COVID-19 dermatology vaccine registry from Esther Freeman, MD and teledermatology from Jules Lipoff, MD. Upneeq, a newly launched oxymetazoline eyedrop from RVL pharmAK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-